子宮頸がん
Development and validation of predictive model for emesis in cervical cancer patients receiving concurrent chemoradiotherapy based on multi-institutional retrospective study.Yoshida K, Morita H, Nakai M, et al. Sci Rep. 2025 Oct 27;15(1):3…
Three-Dimensional Conformal Radiotherapy Versus Image-Guided Intensity Modulated External Beam Radiotherapy in Locally Advanced Cervical Cancer: A Phase III Randomized Control Study.Rai B, Dey T, Ballari N, et al. Clin Oncol (R Coll Radiol…
Chemoradiotherapy With or Without Simultaneous Integrated Boost for Cervical Cancer With Full-Thickness Stromal Invasion: A Phase 3 Randomized Clinical Trial.Liu S, Fang C, Wu X, et al. JAMA Netw Open. 2025 Sep 2;8(9):e2532501. doi: 10.100…
Randomized Phase III Trial of Adjuvant Radiation versus Chemoradiation in Intermediate-Risk, Early-stage Cervical Cancer following Radical Hysterectomy and Lymphadenectomy: Results from NRG Oncology/GOG-263/KGOG1008.Ryu SY, Deng W, Albuque…
Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG INTERLACE): an international, multicentre, randomised phase 3 trial.McCormack M, …
Neoadjuvant or concurrent atezolizumab with chemoradiation for locally advanced cervical cancer: a randomized phase I trial.Mayadev J, Zamarin D, Deng W, et al. Nat Commun. 2025 Jan 9;16(1):553. doi: 10.1038/s41467-024-55200-2. PMID: 39788…
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-bli…
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial.Lor…
Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial.Monk BJ, Toita T, Wu X, et al. Lancet Oncol. 2023 Dec;24(12):1334-1348. doi: 10.1016/S1470-2045(23)004…
Gynaecological reirradiation with image-guided radiotherapy: Dose response relationship for local control and adverse events in pre-immunotherapy era.Chopra S, Manjunath NV, Gupta A, et al. Radiother Oncol. 2025 Jul 28:111064. DOI: 10.1016…
Surgery plus post-operative radiotherapy versus definitive chemoradiotherapy in locally advanced endocervical adenocarcinoma.Baek JY, Park W, Cho WK, et al. Int J Gynecol Cancer. 2025 Jul 11;35(9):102013. DOI: 10.1016/j.ijgc.2025.102013. E…
Tegafur-uracil maintenance chemotherapy post-chemoradiotherapy for cervical cancer: Randomized trial.Hasegawa K, Nishio S, Yamamoto K, et al. Eur J Cancer. 2025 Mar 26;219:115304. DOI: 10.1016/j.ejca.2025.115304.115304. Epub 2025 Feb 15. P…
Incorporation of triapine (T) to cisplatin chemoradiation (CRT) for locally advanced cervical and vaginal cancer: Results from NRG-GY006, a phase III randomized trial.Leath CA 3rd, Deng W, Mell LK, et al. Gynecol Oncol. 2025 Apr;195:122-13…
